Bone morphogenetic protein-9 compositions
US5661007A · kind A · utility
54Cited by
23References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 1993 |
| Grant date | Aug 26, 1997 |
| Priority date | — |
| Expiry date | Apr 22, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Purified bone morphogenetic protein-9 (BMP-9) proteins and processes for producing them are disclosed, The proteins may be used in the treatment of bone and cartilage defects and in wound healing and related tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.